tapebrief
ROL · Q2 2025
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

ROL · Q3 2025 Earnings

Rollins, Inc.

Reported October 29, 2025

30-second summary

Rollins delivered $1.026B in Q3 revenue (+12.0% YoY) with organic growth of 7.2%, and the algorithm shifted from defending margins to expanding them: Q3 incremental margins hit 35.4% (31% ex-insurance adjustments), well above the 28-30% framework management volunteered last quarter. Commercial organic accelerated to 8.3% (from 8.4% — effectively held), termite organic jumped to 10.8% (from 10.3%), and CELA is now tracking mid-70s revenue versus the mid-60s acquisition underwrite. Residential organic at 5.2% recovered from Q2's 4.9% but still sits below the 6% bar — the one watch-list item that did not resolve cleanly.

Headline numbers

EPS

Q3 FY2025

$0.35

Revenue

Q3 FY2025

$1.03B

+12.0% YoY

Gross margin

Q3 FY2025

54.4%

Free cash flow

Q3 FY2025

$0.18B

Operating margin

Q3 FY2025

21.9%

Key financials

Q3 FY2025
MetricQ3 FY2025YoYQ2 FY2025QoQ
Revenue$1.03B+12.0%$1.00B+2.7%
EPS$0.35—$0.30+16.7%
Gross margin54.4%—53.8%+60bps
Operating margin21.9%—19.8%+210bps
Free cash flow$0.18B—$0.17B+8.9%

Guidance

Full-year guidance reaffirmed across organic growth (7–8%), M&A contribution (3–4%), and FCF conversion (>100%); company adds explicit double-digit earnings growth target and reiterates margin expansion objective.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

New guidance

MetricPeriodGuideYoY
Earnings GrowthFY2025Double-digit—
Incremental Margin ProfileFY2025Improving—

Reaffirmed unchanged this quarter: Organic Revenue Growth (7% to 8%), Revenue Growth from M&A (3% to 4%), Free Cash Flow Conversion (above 100%)

Segment KPIs

Q3 FY2025
SegmentQ3 FY2025YoY
Residential$0.476B+11.2%
Commercial$0.335B+11.8%
Termite and Ancillary$0.205B+15.2%
Franchise and Other$0.01B-4.3%
Organic Residential Revenue Growth5.2%—
Organic Commercial Revenue Growth8.3%—
Organic Termite and Ancillary Revenue Growth10.8%—

Other KPIs

Q3 FY2025
SegmentQ3 FY2025
Organic Revenue Growth7.2%
Adjusted Operating Margin22.6%
Adjusted EBITDA Margin25.2%
Free Cash Flow Conversion111.8%
Leverage Ratio0.8x

Management tone

Q1 anchor unavailable → Q2 "investment phase delivering" → Q3 "harvest phase confirmed, margin frame upgraded."

The incremental margin framework moved from directional commentary to formal guidance. Last quarter Ken Krause volunteered "probably not unreasonable to think 28 to 30%" as a soft target. This quarter the press release commentary cites incremental margins of 35.4% in Q3, ~31% excluding insurance adjustments, with YTD approaching 25%, and management elevated "improving our incremental margin profile" into stated FY guidance. The 31% ex-adjustments figure is the durable number — it sits above the upper bound of the Q2 framework, suggesting the prior frame was set conservatively.

Commercial transitioned from "graduating engine" to "proven engine." In Q2 the elevation of a Commercial COO was the signal that the segment had moved from experiment to core. This quarter commercial organic held at 8.3% — sustaining the highest-in-recent-memory level rather than reverting. Management framed it as: "Orkin Commercial delivered double-digit recurring growth in the third quarter," matching Q2 language verbatim. Repetition without escalation, paired with sustained numbers, is a stronger signal than novel claims.

CELA acquisition outperformance was upgraded explicitly. Q2 had no CELA breakout; Q3 commentary surfaces that CELA revenue is tracking mid-70s in year one versus mid-60s underwrite — a ~15% beat on the deal model in the first 12 months, with neutral-to-accretive earnings immediately. This is the cleanest data point validating the 3-4% M&A contribution guide despite flagged PE competition.

Earnings framing tightened. "Double-digit earnings growth" is now an explicit target in management commentary rather than aspirational language. Combined with 0.8x leverage, 111.8% FCF conversion, and 35%+ incremental margins, the company is signaling visibility through year-end — not hedging.

Recurring themes management leaned on this quarter:

Organic growth acceleration across all segments (7.2% total, with commercial up 8.3% and termite up 10.8%)Incremental margin expansion and pricing power (35%+ incremental margins, CPI+ pricing sustained)Commercial division investments yielding productivity and double-digit recurring growthCELA acquisition exceeding expectations with seamless integration and mid-70s revenueCash flow conversion strength (31% growth, 120% conversion rate year-to-date)Multi-brand, diversified customer acquisition strategy insulating from AI/SEO disruptions

Risks management surfaced:

Short-cycle residential business vulnerability to weather impacts and hurricane season disruptionIncreased PE competition in M&A market for pest control acquisitionsAI-driven search engine optimization changes affecting digital lead quality and marketing ROIFleet and vehicle pricing volatility as headwind to marginsMedical and auto insurance claims reserve increases impacting people costs

Answers to last quarter's watch list

Whether commercial organic sustains above 8%. Q3 organic came in at 8.3%, effectively matching Q2's 8.4% and validating the COO elevation. Two consecutive quarters above 8% establishes a trend rather than a one-quarter pop.
Resolved positively
Residential organic recovery to ≥6%. Residential organic came in at 5.2%, up ~30bps from 4.9% in Q2 but still below the 6% bar. The press release notes recurring residential business "approaching 6%" with September improvement, but the consolidated number didn't clear the threshold. The Google AI lead-quality narrative gets another quarter of benefit of the doubt, not validation.
Continue monitoring
Incremental margin delivery against the 28-30% framework. Q3 incremental margins hit 35.4% (31% ex-insurance adjustments), exceeding the upper bound of last quarter's framework. Adjusted EBITDA margin expanded to 25.2% from 23.1% in Q2. Legacy auto claims drag did not absorb the operating leverage.
Resolved positively
FY organic guide at Q3 print. FY organic guide held at 7-8% rather than narrowing to the upper half. YTD organic implied at ~7.3% gives the company room either way; the decision not to narrow suggests prudence given Q4 hurricane exposure rather than weakness.
Continue monitoring
M&A cadence inside the 3-4% contribution guide. M&A contribution guide reaffirmed at 3-4%, with CELA explicitly called out as outperforming underwrite (mid-70s vs. mid-60s revenue). Rollins did not signal a pullback or a stretch on valuation despite Q2's PE-competition flag.
Resolved positively

What to watch into next quarter

Residential organic clearing 6% in Q4. A third consecutive sub-6% print would force a rethink of the "AI leads filter to quality" thesis; the September acceleration management cites needs to show up in the consolidated print, not just the recurring sub-segment.

Whether the incremental margin frame gets formally reset. If management quantifies "improving" into a number on the Q4 call (e.g. 30%+ as the new floor), it confirms 28-30% was conservative. Silence would suggest they want flexibility against potential 2026 cost reinvestment.

FY organic landing inside the 7-8% range, with the implied Q4 organic exit rate. YTD ~7.3% organic means Q4 needs ~6.7-8.5% organic to hold the range. A Q4 exit above 8% sets up an upper-half 2026 guide; below 7% concedes momentum.

CELA's contribution in year-two framing. The mid-70s vs. mid-60s outperformance was a year-one print; whether management commits to retention of that revenue base into 2026 will signal whether the deal moves from accretive to thesis-defining for M&A capital allocation.

Whether 0.8x leverage triggers a capital return shift. With FCF conversion at 111.8% and leverage at 0.8x, the company has capacity for either accelerated M&A or buyback. Either move would be a strategic tell.

Sources

  1. Rollins Q3 2025 press release (Form 8-K Ex. 99.1), filed 2025-10-29. https://www.sec.gov/Archives/edgar/data/84839/000008483925000097/rol-20251029xex991.htm
  2. Rollins Q2 2025 Tapebrief, published 2025-07-23 (for prior-quarter trend context).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.